84 results
8-K
EX-10.3
NNVC
NanoViricides Inc
16 Feb 24
Entry into a Material Definitive Agreement
4:53pm
8-K
EX-10.2
NNVC
NanoViricides Inc
16 Feb 24
Entry into a Material Definitive Agreement
4:53pm
8-K
EX-10.5
NNVC
NanoViricides Inc
16 Feb 24
Entry into a Material Definitive Agreement
4:53pm
8-K
EX-10.4
NNVC
NanoViricides Inc
16 Feb 24
Entry into a Material Definitive Agreement
4:53pm
10-K
2023 FY
EX-10.25
NNVC
NanoViricides Inc
Annual report
13 Oct 23
4:30pm
8-K
EX-10.2
9bz7toujw8g41
1 Sep 23
Entry into a Material Definitive Agreement
4:46pm
8-K
EX-10.3
j5a7cs7utpg v8ye1
1 Sep 23
Entry into a Material Definitive Agreement
4:46pm
8-K
EX-10.1
c2phte 84
31 Mar 23
Entry into a Material Definitive Agreement
5:17pm
8-K
EX-10.2
easa5sybwppy
11 Oct 22
Departure of Directors or Certain Officers
4:32pm
8-K
EX-10.1
94f7j6 5ud
15 Sep 21
NanoViricides Completes Licensing for Coronavirus Field which Includes Current COVID-19 Drug Development
4:36pm
8-K
EX-10.2
6jeoh n02dp32
15 Sep 21
NanoViricides Completes Licensing for Coronavirus Field which Includes Current COVID-19 Drug Development
4:36pm
8-K
EX-10.1
oibvkbmbv2fn727
19 Nov 20
NanoViricides Strengthens its Board of Directors with Addition of Industry Veteran Brian Zucker, CPA
4:53pm
8-K
EX-10.1
0ld7gfyf66 3do2wv8s
13 Jul 20
Nanoviricides Closes on $11.5 Million Underwritten Public Offering of Common Stock
4:52pm
8-K
EX-10.1
7gn05u 1cgy8
22 May 20
NanoViricides Announces Pricing of $10.2 Million Registered Direct Offering
4:10pm
8-K
EX-10.2
akdspgtbvjbwricwagm
22 May 20
NanoViricides Announces Pricing of $10.2 Million Registered Direct Offering
4:10pm
8-K
EX-10.1
2xbspk5js0963ahbks6
19 May 20
Departure of Directors or Certain Officers
5:15pm
8-K
EX-10.1
lp9g2
11 Feb 20
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.2
8jtk7bso
28 Jan 20
Entry into a Material Definitive Agreement
6:11am
8-K
EX-10.1
m3cgfln4
28 Jan 20
Entry into a Material Definitive Agreement
6:11am